
standard treatment gives you a chance
we give you an advantage
We don't just add to your treatment. We make it
work harder, hit deeper, and deliver better outcomes.
Backed by the world’s leading clinical researchers,
we bring you the proven therapies and support that amplify your treatment, reduce burden and redefine survivorship.
we support your entire system
Clinically governed treatments
delivered together as a structured program.





Each FitMed program combines clinically prescribed treatments across key health domains, personalised to you, coordinated by your care team, and delivered as one integrated plan.
your treatment pathway
A clinically governed treatment pathway, built around you.
Your journey begins with a clinical consultation and assessment.

Clinical assessment
We start with a structured clinical consultation to understand your diagnosis, treatment plan, medical history, and personal goals. Where needed, we help coordinate additional clinical tests and data to ensure your care is informed, appropriate, and personalised.

Personalised treatment program
Using your clinical information, FitMed clinicians design a coordinated treatment program across key health domains, including exercise medicine, psychosocial care, medical nutrition, therapeutic education, and supportive care. Each program is clinically prescribed, governed, and tailored to support your treatment, recovery, and longer-term outcomes.

Delivery beyond the clinic
Your treatment is delivered through FitMed’s connected care platform, allowing you to actively take part in your care at home, in your community, or alongside existing services. We co-ordinate clinicians, tools, and progress tracking so your care remains structured, supported, and connected to your broader medical team.
improving health outcomes for
We don't just supplement your treatment. We make it
work harder, hit deeper, and deliver better outcomes.
up to 42%
lower risk of disease specific mortality
up to 50%
lower risk of disease recurrence
up to 57%
lower risk of disease progression
30 - 50%
less disease related fatigue
up to 50%
reduction in pain and treatment side effects
40%
reduction in psychological distress
59-86%
return to work success
within 6-12 months
300%
increase in chemotherapy infusion
1.5 - 2.5 x
increase in radiation oxygenation
up to 50%
reduction in post-operative complications
30 - 50%
reduction in risk of treatment - induced metabolic decline
up to 100x
more IL-6, enhancing immune surveillance & anti-inflammatory responses
up to 60%
reduction in tumor growth due to mobilisation of natural killer cells
up to 8%
improvement in lumbar spine bone mineral density
2 x
improvement in survivorship rates when integrated with standard treatment
2 x
faster recovery speed compared to standard treatment pathways
24 hrs
sustained elevation of natural killer cell activity
51%
reduction in fracture risk
59-86%
return to work success
within 6-12 months
300%
increase in chemotherapy infusion
1.5 - 2.5 x
increase in radiation oxygenation
up to 50%
reduction in post-operative complications
30 - 50%
reduction in risk of treatment - induced metabolic decline
up to 100x
more IL-6, enhancing immune surveillance & anti-inflammatory responses
up to 60%
reduction in tumor growth due to mobilisation of natural killer cells
up to 8%
improvement in lumbar spine bone mineral density
2 x
improvement in survivorship rates when integrated with standard treatment
2 x
faster recovery speed compared to standard treatment pathways
24 hrs
sustained elevation of natural killer cell activity
51%
reduction in fracture risk
up to 42%
lower risk of disease specific mortality
up to 50%
lower risk of disease recurrence
up to 57%
lower risk of disease progression
30 - 50%
less disease related fatigue
up to 50%
reduction in pain and treatment side effects
40%
reduction in psychological distress
2 x
faster recovery speed compared to standard treatment pathways
24 hrs
sustained elevation of natural killer cell activity
51%
reduction in fracture risk
up to 42%
lower risk of disease specific mortality
up to 50%
lower risk of disease recurrence
30 - 50%
less disease related fatigue
up to 50%
reduction in pain and treatment side effects
40%
reduction in psychological distress
59-86%
return to work success
within 6-12 months
300%
increase in chemotherapy infusion
1.5 - 2.5 x
increase in radiation oxygenation
50%
reduction in post-operative complications
30 - 50%
reduction in risk of treatment - induced metabolic decline
up to 100x
more IL-6, enhancing immune surveillance & anti-inflammatory responses
up to 60%
reduction in tumor growth due to mobilisation of natural killer cells
up to 8%
improvement in lumbar spine bone mineral density
2 x
improvement in survivorship rates when integrated with standard treatment
up to 57%
lower risk of disease progression
Evidence-backed outcomes from structured, clinically governed care
* outcomes reflect study populations from independently reviewed and
published clinical research; individual experiences and results may differ.

reaching more people
with greater impact.
Care shouldn't stop at the clinic door.
FitMed extends clinically governed treatment and support into everyday life, giving patients greater agency, continuity, and support when and where it matters most.
FitMed was built for this moment.
A connected clinical ecosystem that helps patients access evidence-based treatments sooner, supports care teams to deliver them more effectively, and enables care to scale without adding burden to the system.
Healthcare was never built for today’s complexity.
Patients wait too long, clinicians are stretched too thin, and proven treatments don’t always reach the people who could benefit from them most.
connected clinical care ™
a new health ecosystem
built around you and your care team

find the care that fits you
© 2022-2026 FitMed







